Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
With filing in Sanofi and Mylan insulin lawsuit, FTC amps up scrutiny on pharma's patent tactics
With filing in Sanofi and Mylan insulin lawsuit, FTC amps up scrutiny on pharma's patent tactics
Fierce Pharma
Sanofi
Mylan
legal
FTC
insulin
diabetes
Flag link:
Beyond insulin: Medical expands patient access to diabetes supplies
Beyond insulin: Medical expands patient access to diabetes supplies
Medical Marketing and Media
insulin
diabetes
Medi-Cal
Flag link:
Novo Nordisk sets aside $6bn to boost production capacity
Novo Nordisk sets aside $6bn to boost production capacity
Pharmaphorum
Novo Nordisk
diabetes
obesity
drug manufacturing
Flag link:
Novo Nordisk to discontinue Levemir insulin in U.S. market
Novo Nordisk to discontinue Levemir insulin in U.S. market
Reuters
Novo Nordisk
Levemir
insulin
diabetes
Flag link:
An obesity drug biotech gets buy-in from Eli Lilly, venture firms
An obesity drug biotech gets buy-in from Eli Lilly, venture firms
BioPharma Dive
OrsoBio
Eli Lilly
funding
obesity
diabetes
Flag link:
Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.
Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.
Motley Fool
Novo Nordisk
Ozempic
Wegovy
diabetes
weight loss
Flag link:
Belgium plans temporary ban on use of Ozempic for weight loss
Belgium plans temporary ban on use of Ozempic for weight loss
Yahoo/Reuters
Novo Nordisk
Ozempic
diabetes
weight loss
Belgium
drug shortages
Flag link:
Insulet Omnipod 5 iPhone App FDA Cleared
Insulet Omnipod 5 iPhone App FDA Cleared
Medical Devices and Diagnostics Industry
Medtech
Insulet
Omnipod 5
FDA
insulin delivery
diabetes
Flag link:
Fresenius Medical: effect of drugs like Ozempic on patient numbers is neutral
Fresenius Medical: effect of drugs like Ozempic on patient numbers is neutral
Yahoo/Reuters
Fresenius Medical Care
Ozempic
diabetes
weight loss
Novo Nordisk
dialysis
Medtech
Flag link:
Novo Ends Semaglutide Kidney Study Early Due to Strong Efficacy Signals
Novo Ends Semaglutide Kidney Study Early Due to Strong Efficacy Signals
BioSpace
Novo Nordisk
semaglutide
clinical trials
diabetes
chronic kidney disease
Flag link:
Abbott’s Biowearable Performs Well In U.K. Ahead Of U.S. Launch
Abbott’s Biowearable Performs Well In U.K. Ahead Of U.S. Launch
Forbes
Abbott Labs
biowearables
UK
diabetes
Lingo
devices
Medtech
Flag link:
2 Reasons Why Eli Lilly's Mounjaro Might Beat Novo Nordisk's Ozempic, and 2 Reasons Why It Might Not
2 Reasons Why Eli Lilly's Mounjaro Might Beat Novo Nordisk's Ozempic, and 2 Reasons Why It Might Not
Motley Fool
Novo Nordisk
Eli Lilly
Ozempic
Mounjaro
diabetes
weight loss
Flag link:
At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide
At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide
Fierce Pharma
Viatris
generics
Novo Nordisk
Ozempic
Wegovy
diabetes
patents
USPTO
Flag link:
Lilly names new diabetes and obesity chief as Mounjaro sales take off
Lilly names new diabetes and obesity chief as Mounjaro sales take off
BioPharma Dive
Eli Lilly
Mounjaro
diabetes
Flag link:
FDA Adds New Warning for Ileus to Ozempic Label
FDA Adds New Warning for Ileus to Ozempic Label
HCP Live
Novo Nordisk
Ozempic
diabetes
weight losss
FDA
ileus
labeling
Flag link:
Why a hidden message in Ozempic’s logo represents a big shift in drug branding
Why a hidden message in Ozempic’s logo represents a big shift in drug branding
Fast Company
Novo Nordisk
Ozempic
logo
branding
diabetes
weight loss
Flag link:
FDA panel votes against diabetes implant due to safety concerns
FDA panel votes against diabetes implant due to safety concerns
Reuters
Intarcia
diabetes
FDA
ITCA 650
Medtech
Flag link:
Intarcia, a failed diabetes "unicorn," could be resurrected
Intarcia, a failed diabetes "unicorn," could be resurrected
Axios
Intarcia
FDA
diabetes
Flag link:
Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
CNBC
Eli Lilly
legal
Mounjaro
diabetes
Flag link:
Novo Nordisk taps Aspen to help produce insulin for Africa
Novo Nordisk taps Aspen to help produce insulin for Africa
Fierce Pharma
Novo Nordisk
diabetes
Africa
insulin
Aspen Pharmacare
drug manufacturing
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »